Non-invasive and quantifiable diagnosis of Parkinson’s disease is an ongoing challenge for researchers. In this study, we worked on the CEST signal at 2ppm (CEST@2ppm) in the substantia nigra of acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse models at three different time points including pre and 3rd day, 10th day after treatment. CEST@2ppm after 5-pool lorentzian fitting showed a statistically significant difference after MPTP injection and metrics based on this fitting model ( MTRrex and AREX) also indicated positive correlation of CEST@2ppm with the SN damages while the statistic difference of 3rd and 10th day was not significant. This quantifying CEST signal may reflect the pathological mechanism of PD in SN.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords